Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.770
+0.050 (1.06%)
At close: May 19, 2026, 4:00 PM EDT
4.448
-0.322 (-6.76%)
After-hours: May 19, 2026, 7:50 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $25.71 million as of May 19, 2026. Its market cap has increased by 182.53% in one year.
Market Cap
25.71M
Enterprise Value
6.27M
1-Year Change
182.53%
Ranking
Category
Stock Price
$4.77
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $25.71M, an increase of 138.34%. That is a compound annual growth rate of 85.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 25.71M | 23.25% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 27.17M |
| NeuroSense Therapeutics | 26.87M |
| Polyrizon | 26.41M |
| Tempest Therapeutics | 26.18M |
| Barinthus Biotherapeutics | 25.94M |
| ABVC BioPharma | 25.45M |
| Werewolf Therapeutics | 24.74M |
| GridAI Technologies | 23.81M |